“Over the last two years, Kathrin’s legendary resolve, stellar scientific intuition, and vaccine development expertise ushered in the first glimmer of hope for humanity in the middle of the pandemic,” Chief Scientific Officer Mikael Dolsten mentioned in a LinkedIn pos https://bit.ly/3vVBtB4t asserting the retirement.
Pfizer developed the two-dose shot in collaboration with Germany’s BioNTech. The vaccine grew to become obtainable within the United States below an emergency use authorization in late 2020 and is now the Western world’s most generally used COVID-19 shot.
Jansen, who grew to become the senior vice chairman of vaccine analysis and growth in 2015, had been the chief scientific officer of the drugmaker’s vaccine analysis and early growth analysis unit.
She beforehand led vaccine analysis at vaccines and well being care merchandise maker Wyeth, which was acquired by Pfizer over a decade in the past.
When contacted, Pfizer pointed to the LinkedIn submit by Dolsten with out offering extra remark.